FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220776875> ?p ?o ?g. }

• W4220776875 abstract "Currently, there is no effective drugs for treating clinically COVID-19 except dexamethasone. We previously revealed that human identical sequences of SARS-CoV-2 promote the COVID-19 progression by upregulating hyaluronic acid (HA). As the inhibitor of HA synthesis, hymecromone is an approved prescription drug used for treating biliary spasm. Here, we aimed to investigate the relation between HA and COVID-19, and evaluate the therapeutic effects of hymecromone on COVID-19. Firstly, HA was closely relevant to clinical parameters, including lymphocytes (n = 158; r = -0.50; P < 0.0001), C-reactive protein (n = 156; r = 0.55; P < 0.0001), D-dimer (n = 154; r = 0.38; P < 0.0001), and fibrinogen (n = 152; r = 0.37; P < 0.0001), as well as the mass (n = 78; r = 0.43; P < 0.0001) and volume (n = 78; r = 0.41; P = 0.0002) of ground-glass opacity, the mass (n = 78; r = 0.48; P < 0.0001) and volume (n = 78; r = 0.47; P < 0.0001) of consolidation in patient with low level of hyaluronan (HA < 48.43 ng/mL). Furthermore, hyaluronan could directly cause mouse pulmonary lesions. Besides, hymecromone remarkably reduced HA via downregulating HAS2/HAS3 expression. Moreover, 89% patients with hymecromone treatment had pulmonary lesion absorption while only 42% patients in control group had pulmonary lesion absorption (P < 0.0001). In addition, lymphocytes recovered more quickly in hymecromone-treated patients (n = 8) than control group (n = 5) (P < 0.05). These findings suggest that hymecromone is a promising drug for COVID-19 and deserves our further efforts to determine its effect in a larger cohort." @default.
• W4220776875 created "2022-04-03" @default.
• W4220776875 creator A5000432967 @default.
• W4220776875 creator A5000918608 @default.
• W4220776875 creator A5003298311 @default.
• W4220776875 creator A5005805900 @default.
• W4220776875 creator A5009005728 @default.
• W4220776875 creator A5018715513 @default.
• W4220776875 creator A5020929464 @default.
• W4220776875 creator A5021015100 @default.
• W4220776875 creator A5021983179 @default.
• W4220776875 creator A5029484872 @default.
• W4220776875 creator A5030775386 @default.
• W4220776875 creator A5034135434 @default.
• W4220776875 creator A5042566458 @default.
• W4220776875 creator A5045085415 @default.
• W4220776875 creator A5048095758 @default.
• W4220776875 creator A5054578837 @default.
• W4220776875 creator A5058371393 @default.
• W4220776875 creator A5063190107 @default.
• W4220776875 creator A5071074966 @default.
• W4220776875 creator A5073579725 @default.
• W4220776875 creator A5081961473 @default.
• W4220776875 creator A5084484621 @default.
• W4220776875 creator A5086759438 @default.
• W4220776875 date "2022-03-18" @default.
• W4220776875 modified "2023-10-17" @default.
• W4220776875 title "Hymecromone: a clinical prescription hyaluronan inhibitor for efficiently blocking COVID-19 progression" @default.
• W4220776875 cites W1921991607 @default.
• W4220776875 cites W1966303142 @default.
• W4220776875 cites W2033677151 @default.
• W4220776875 cites W2035240370 @default.
• W4220776875 cites W2057694188 @default.
• W4220776875 cites W2105222737 @default.
• W4220776875 cites W2116502138 @default.
• W4220776875 cites W2148076415 @default.
• W4220776875 cites W2771094816 @default.
• W4220776875 cites W2985692802 @default.
• W4220776875 cites W3001118548 @default.
• W4220776875 cites W3007940623 @default.
• W4220776875 cites W3008827533 @default.
• W4220776875 cites W3009875419 @default.
• W4220776875 cites W3012696170 @default.
• W4220776875 cites W3013304160 @default.
• W4220776875 cites W3016535995 @default.
• W4220776875 cites W3016832871 @default.
• W4220776875 cites W3027187955 @default.
• W4220776875 cites W3033072986 @default.
• W4220776875 cites W3036071663 @default.
• W4220776875 cites W3041319886 @default.
• W4220776875 cites W3046693249 @default.
• W4220776875 cites W3082108964 @default.
• W4220776875 cites W3088544507 @default.
• W4220776875 cites W3108672867 @default.
• W4220776875 cites W3111988956 @default.
• W4220776875 cites W3127836793 @default.
• W4220776875 cites W3150805415 @default.
• W4220776875 cites W3161355478 @default.
• W4220776875 cites W3176010026 @default.
• W4220776875 cites W3189646261 @default.
• W4220776875 cites W3192713004 @default.
• W4220776875 cites W3198164108 @default.
• W4220776875 cites W4206347872 @default.
• W4220776875 cites W4210246825 @default.
• W4220776875 cites W4210642183 @default.
• W4220776875 doi "https://doi.org/10.1038/s41392-022-00952-w" @default.
• W4220776875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35304437" @default.
• W4220776875 hasPublicationYear "2022" @default.
• W4220776875 type Work @default.
• W4220776875 citedByCount "11" @default.
• W4220776875 countsByYear W42207768752022 @default.
• W4220776875 countsByYear W42207768752023 @default.
• W4220776875 crossrefType "journal-article" @default.
• W4220776875 hasAuthorship W4220776875A5000432967 @default.
• W4220776875 hasAuthorship W4220776875A5000918608 @default.
• W4220776875 hasAuthorship W4220776875A5003298311 @default.
• W4220776875 hasAuthorship W4220776875A5005805900 @default.
• W4220776875 hasAuthorship W4220776875A5009005728 @default.
• W4220776875 hasAuthorship W4220776875A5018715513 @default.
• W4220776875 hasAuthorship W4220776875A5020929464 @default.
• W4220776875 hasAuthorship W4220776875A5021015100 @default.
• W4220776875 hasAuthorship W4220776875A5021983179 @default.
• W4220776875 hasAuthorship W4220776875A5029484872 @default.
• W4220776875 hasAuthorship W4220776875A5030775386 @default.
• W4220776875 hasAuthorship W4220776875A5034135434 @default.
• W4220776875 hasAuthorship W4220776875A5042566458 @default.
• W4220776875 hasAuthorship W4220776875A5045085415 @default.
• W4220776875 hasAuthorship W4220776875A5048095758 @default.
• W4220776875 hasAuthorship W4220776875A5054578837 @default.
• W4220776875 hasAuthorship W4220776875A5058371393 @default.
• W4220776875 hasAuthorship W4220776875A5063190107 @default.
• W4220776875 hasAuthorship W4220776875A5071074966 @default.
• W4220776875 hasAuthorship W4220776875A5073579725 @default.
• W4220776875 hasAuthorship W4220776875A5081961473 @default.
• W4220776875 hasAuthorship W4220776875A5084484621 @default.
• W4220776875 hasAuthorship W4220776875A5086759438 @default.
• W4220776875 hasBestOaLocation W42207768751 @default.
• W4220776875 hasConcept C105702510 @default.
• W4220776875 hasConcept C121608353 @default.
• W4220776875 hasConcept C126322002 @default.

• next